US 11,883,688 B2
Energy based fat reduction
Michael H. Slayton, Phoenix, AZ (US); and Peter G. Barthe, Phoenix, AZ (US)
Assigned to Guided Therapy Systems, LLC, Mesa, AZ (US)
Filed by Guided Therapy Systems, LLC, Mesa, AZ (US)
Filed on Oct. 22, 2021, as Appl. No. 17/508,841.
Application 17/508,841 is a continuation of application No. 17/127,691, filed on Dec. 18, 2020, granted, now 11,179,580.
Application 17/127,691 is a continuation of application No. 16/794,701, filed on Feb. 19, 2020, granted, now 10,888,716, issued on Jan. 12, 2021.
Application 16/794,701 is a continuation of application No. 16/272,427, filed on Feb. 11, 2019, granted, now 10,603,519, issued on Mar. 31, 2020.
Application 16/272,427 is a continuation of application No. 15/996,249, filed on Jun. 1, 2018, granted, now 10,238,894, issued on Mar. 26, 2019.
Application 15/996,249 is a continuation of application No. 15/829,175, filed on Dec. 1, 2017, granted, now 10,010,721, issued on Jul. 3, 2018.
Application 15/829,175 is a continuation of application No. 15/650,525, filed on Jul. 14, 2017, granted, now 9,833,639, issued on Dec. 5, 2017.
Application 15/650,525 is a continuation of application No. 15/380,267, filed on Dec. 15, 2016, granted, now 9,713,731, issued on Jul. 25, 2017.
Application 15/380,267 is a continuation of application No. 15/041,804, filed on Feb. 11, 2016, granted, now 9,533,175, issued on Jan. 3, 2017.
Application 15/041,804 is a continuation of application No. 14/550,772, filed on Nov. 21, 2014, granted, now 9,283,409, issued on Mar. 15, 2016.
Application 14/550,772 is a continuation of application No. 14/192,520, filed on Feb. 27, 2014, granted, now 8,920,324, issued on Dec. 30, 2014.
Application 14/192,520 is a continuation of application No. 12/646,609, filed on Dec. 23, 2009, granted, now 8,663,112, issued on Mar. 4, 2014.
Application 12/646,609 is a continuation in part of application No. 11/163,154, filed on Oct. 6, 2005, granted, now 8,133,180, issued on Mar. 13, 2012.
Claims priority of provisional application 61/140,725, filed on Dec. 24, 2008.
Claims priority of provisional application 60/616,753, filed on Oct. 6, 2004.
Prior Publication US 2022/0040503 A1, Feb. 10, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 7/00 (2006.01); A61B 5/00 (2006.01); A61B 8/08 (2006.01); A61B 8/00 (2006.01); B06B 1/06 (2006.01); G01S 7/52 (2006.01); G01S 15/89 (2006.01); A61N 7/02 (2006.01); A61B 90/00 (2016.01); A61B 8/14 (2006.01)
CPC A61N 7/00 (2013.01) [A61B 5/4869 (2013.01); A61B 8/0858 (2013.01); A61B 8/429 (2013.01); A61B 8/4483 (2013.01); A61B 8/483 (2013.01); A61N 7/02 (2013.01); B06B 1/0607 (2013.01); B06B 1/0622 (2013.01); G01S 7/5208 (2013.01); G01S 15/8906 (2013.01); G01S 15/899 (2013.01); G01S 15/8993 (2013.01); H05K 999/99 (2013.01); A61B 8/14 (2013.01); A61B 8/4455 (2013.01); A61B 2090/378 (2016.02); A61N 2007/0008 (2013.01); A61N 2007/0052 (2013.01); A61N 2007/027 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An ultrasound probe, comprising:
a piezoelectric ultrasound transducer,
wherein the piezoelectric ultrasound transducer delivers ultrasound energy at a frequency,
wherein the piezoelectric ultrasound transducer is configured for delivering the ultrasound energy at a temperature to coagulate a fat cells in one or more fat lobuli at a depth under a superficial layer of skin,
wherein the piezoelectric ultrasound transducer is configured for acoustic coupling to the superficial layer of skin,
wherein the piezoelectric ultrasound transducer forms a thermal coagulation region at the depth for coagulating the fat cells in the one or more fat lobuli.